We are upgrading the repository! A content freeze is in effect until December 11, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.

Show simple item record

dc.contributor.authorSingh, Nishant K.
dc.contributor.authorRiley, Timothy P.
dc.contributor.authorBaker, Sarah Catherine B.
dc.contributor.authorBorrman, Tyler M.
dc.contributor.authorWeng, Zhiping
dc.contributor.authorBaker, Brian M.
dc.date2022-08-11T08:07:58.000
dc.date.accessioned2022-08-23T15:37:56Z
dc.date.available2022-08-23T15:37:56Z
dc.date.issued2017-10-01
dc.date.submitted2017-11-15
dc.identifier.citationJ Immunol. 2017 Oct 1;199(7):2203-2213. doi: 10.4049/jimmunol.1700744. <a href="https://doi.org/10.4049/jimmunol.1700744">Link to article on publisher's site</a>
dc.identifier.issn0022-1767 (Linking)
dc.identifier.doi10.4049/jimmunol.1700744
dc.identifier.pmid28923982
dc.identifier.urihttp://hdl.handle.net/20.500.14038/25831
dc.description.abstractT cell specificity emerges from a myriad of processes, ranging from the biological pathways that control T cell signaling to the structural and physical mechanisms that influence how TCRs bind peptides and MHC proteins. Of these processes, the binding specificity of the TCR is a key component. However, TCR specificity is enigmatic: TCRs are at once specific but also cross-reactive. Although long appreciated, this duality continues to puzzle immunologists and has implications for the development of TCR-based therapeutics. In this review, we discuss TCR specificity, emphasizing results that have emerged from structural and physical studies of TCR binding. We show how the TCR specificity/cross-reactivity duality can be rationalized from structural and biophysical principles. There is excellent agreement between predictions from these principles and classic predictions about the scope of TCR cross-reactivity. We demonstrate how these same principles can also explain amino acid preferences in immunogenic epitopes and highlight opportunities for structural considerations in predictive immunology.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=28923982&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.4049/jimmunol.1700744
dc.subjectBiochemistry, Biophysics, and Structural Biology
dc.subjectBioinformatics
dc.subjectComputational Biology
dc.subjectImmunology and Infectious Disease
dc.subjectIntegrative Biology
dc.subjectSystems Biology
dc.titleEmerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes
dc.typeJournal Article
dc.source.journaltitleJournal of immunology (Baltimore, Md. : 1950)
dc.source.volume199
dc.source.issue7
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/bioinformatics_pubs/122
dc.identifier.contextkey11052640
html.description.abstract<p>T cell specificity emerges from a myriad of processes, ranging from the biological pathways that control T cell signaling to the structural and physical mechanisms that influence how TCRs bind peptides and MHC proteins. Of these processes, the binding specificity of the TCR is a key component. However, TCR specificity is enigmatic: TCRs are at once specific but also cross-reactive. Although long appreciated, this duality continues to puzzle immunologists and has implications for the development of TCR-based therapeutics. In this review, we discuss TCR specificity, emphasizing results that have emerged from structural and physical studies of TCR binding. We show how the TCR specificity/cross-reactivity duality can be rationalized from structural and biophysical principles. There is excellent agreement between predictions from these principles and classic predictions about the scope of TCR cross-reactivity. We demonstrate how these same principles can also explain amino acid preferences in immunogenic epitopes and highlight opportunities for structural considerations in predictive immunology.</p>
dc.identifier.submissionpathbioinformatics_pubs/122
dc.contributor.departmentDepartment of Biochemistry and Molecular Pharmacology
dc.contributor.departmentProgram in Bioinformatics and Integrative Biology
dc.source.pages2203-2213


This item appears in the following Collection(s)

Show simple item record